Imagine if there was an independent audit of FDA's decisions. I'm pretty sure they would not find batch to batch consistency. Maybe also quite a few potency problems. Not to mention the odd person without a clear ethical Mechanism of Action. I wonder how they would score on their ability to green light life saving and changing products to market for those that can not tolerate the side effects of traditional pharmaceuticals or for those where these pills have failed to stop the progression of disease?
Imagine if there was an independent audit of FDA's decisions....
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.065(4.69%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.50 | $1.38 | $7.016M | 4.856M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10425 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 44243 | 5 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |